Flytjandi: Berglind Eva Benediktsdóttir

Optimization of extracellular vesicle isolation using CD81 immunoaffinity capture

Engineering and formulation efforts for extracellular vesicles with targeting properties against triple negative breast cancers

Optimization of extracellular vesicle isolation using CD81 immunoaffinity capture

Engineering and formulation efforts for extracellular vesicles with targeting properties against triple negative breast cancers

Engineered extracellular vesicles from a HEK293 cell line as a potential nanosized drug delivery system to tackle specific cancer subtypes

Notkun teymisnáms (e. Team-based learning, TBL) í lyfjafræði og upplifun nemenda af því

Scroll to Top

Á þessu vefsvæði eru notaðar vafrakökur.